To ensure the accuracy of our patient satisfaction scores, we require that providers who see patients receive
a minimum number of completed patient-submitted surveys before their reviews are listed on their profiles.
Star ratings on this site are collected on a rolling basis from the previous 12 months.
Additionally, some of the physicians listed on our site do not see patients directly, and therefore, do not receive
evaluation and ratings from patients.
A cancer diagnosis can be an overwhelming and life-altering event. I am honored to have the privilege of guiding patients and their families through each step of their care. The rapid pace of oncology research has led to the introduction of many novel and targeted therapies, and I take a collaborative approach to personalizing these treatment options for my patients. I am excited to join a comprehensive and multidisciplinary team at Fox Chase that can support patients and families through their treatment and recovery.
2005 - BS, Mathematics, BA, Philosophy, Indiana University, Bloomington, IN, High Distinction with Honors
2017-Present - American Board of Internal Medicine, Internal Medicine
2020-Present - American Board of Internal Medicine, Medical Oncology
2018-Present - American Society of Clinical Oncology, Member in Training
Honors & Awards
2020 - Merit Award, ASCO Annual Meeting
2014 - Alpha Omega Alpha Honor Society, Johns Hopkins School of Medicine
2005 - Betty Neal Hamilton Award, Department of Philosophy, Indiana University
2005 - Phi Beta Kappa Honor Society, Indiana University
2004 - Wilcox Scholarship, Department of Mathematics, Indiana University
2003 - Hennel Memorial Scholarship, Department of Mathematics, Indiana University
2001-2005 - Honors College Scholarship, Indiana University
Developed and authored a multicenter phase II trial investigating venetoclax and rituximab as fist line treatment of mantle cell lymphoma in patient ineligible for aggressive therapy
Investigated incidence, clinical characteristics, outcomes, and response to treatment of patients with large granular lymphocytosis after allogenic blood or marrow transplantation
Developed database of patients with cutaneous T cell lymphoma to investigate risk of second malignancies and possible genetic predisposition
Messmer M, Wake L, Tsai HL, Jones RJ, Varadhan R, Wagner-Johnston N. Large Granular Lymphocytosis With Cytopenias After Allogeneic Blood or Marrow Transplantation: Clinical Characteristics and Response to Immunosuppressive Therapy. Transplant Cell Ther. 2021 Mar;27(3):260.e1-260.e6. doi: 10.1016/j.jtct.2020.12.008. Epub 2020 Dec 16. PMID: 33781530
Messmer M, Tsai HL, Varadhan R, Swinnen LJ, Jones RJ, Ambinder RF, Shanbhag SP, Borowitz MJ, Wagner-Johnston N. R-CHOP without radiation in frontline management of primary mediastinal B-cell lymphoma. Leuk Lymphoma. 2019 May;60(5):1261-1265. doi: 10.1080/10428194.2018.1519812. Epub 2019 Jan 18. PMID: 30656983; PMCID: PMC6472975
The following ratings and reviews are based on verified feedback collected from independently administered
patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions.
Patient identities are withheld to ensure confidentiality and privacy.
Learn more about our Patient Experience Ratings.